Impulse oscillometry may be of value in detecting early manifestations of COPD

Respiratory Medicine

Volumn 106, Issue 8, 2012, Pages 1116-1123

  Frantz, S ^a   Nihlen U ^a   Dencker, M ^a   Engstrom G ^a   Lofdahl C G ^a   Wollmer, P ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

COPD; Impulse oscillometry; Pulmonary reactance; Pulmonary resistance

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMPULSE OSCILLOMETRY SYSTEM; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; PRIORITY JOURNAL; PULMONARY REACTANCE; QUESTIONNAIRE; RESPIRATORY TRACT PARAMETERS; SELF REPORT; SPIROMETER; SPIROMETRY;

AGED; AIRWAY RESISTANCE; BRONCHITIS, CHRONIC; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSCILLOMETRY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY MECHANICS; SPIROMETRY;

EID: 84862530934     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.04.010     Document Type: Article

References (34)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
2. de Marco R, Accordini S, Cerveri I, Corsico A, Anto JM, Kunzli N, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-9.
3. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005;127:1544-52.
4. Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166:329-32.
5. Smith J, Woodcock A. Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:305-14.
6. Landser FJ, Nagles J, Demedts M, Billiet L, van de Woestijne KP. A new method to determine frequency characteristics of the respiratory system. J Appl Physiol 1976;41:101-6.
7. Nagels J, Landser FJ, van der Linden L, Clement J, Van de Woestijne KP. Mechanical properties of lungs and chest wall during spontaneous breathing. J Appl Physiol 1980;49:408-16.
8. Wouters EF, Landser FJ, Polko AH, Visser BF. Physiological analysis of extended-spectrum oscillometry. Respiration 1988;54:263-70.
9. Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol 2005;148:179-94.
10. Oppenheimer BW, Goldring RM, Herberg ME, Hofer IS, Reyfman PA, Liautaud S, et al. Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure. Chest 2007;132:1275-82.
11. Skloot G, Goldman M, Fischler D, Goldman C, Schechter C, Levin S, et al. Respiratory symptoms and physiologic assessment of ironworkers at the World Trade Center disaster site. Chest 2004;125:1248-55.
12. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-60.
13. Hogg JC. Lung structure and function in COPD. Int J Tuberc Lung Dis 2008;12:467-79.
14. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
15. van den Berge M, ten Hacken NH, Cohen J, Douma WR, Postma DS. Small airway disease in asthma and COPD: clinical implications. Chest 2010;139:412-23.
16. Kolsum U, Borrill Z, Roy K, Starkey C, Vestbo J, Houghton C, et al. Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med 2009;103:136-43.
17. Haruna A, Oga T, Muro S, Ohara T, Sato S, Marumo S, et al. Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study. BMC Pulm Med 2010;10:10.
18. Montnemery P, Adelroth E, Heuman K, Johannisson A, Johansson SA, Lindholm LH, et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med 1998;92:1337-45.
19. Nihlen U, Nyberg P, Montnemery P, Lofdahl CG. Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD. Respir Med 2004;98:263-70.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
21. Wise RA, Tashkin DP. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient? Am J Med 2007;120:S14-22.
22. Joo MJ, Au DH, Lee TA. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Transl Res 2009;154:103-10.
23. Contoli M, Bousquet J, Fabbri LM, Magnussen H, Rabe KF, Siafakas NM, et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010;65:141-51.
24. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001;14:341-50.
25. Clement J, Landser FJ, Van de Woestijne KP. Total resistance and reactance in patients with respiratory complaints with and without airways obstruction. Chest 1983;83:215-20.
26. Landser FJ, Clement J, Van de Woestijne KP. Normal values of total respiratory resistance and reactance determined by forced oscillations: influence of smoking. Chest 1982;81:586-91.
27. Pasker HG, Schepers R, Clement J, Van de Woestijne KP. Total respiratory impedance measured by means of the forced oscillation technique in subjects with and without respiratory complaints. Eur Respir J 1996;9:131-9.
28. Crim C, Celli B, Edwards LD, Wouters E, Coxson HO, Tal-Singer R, et al. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respir Med 2011;105:1069-78.
29. Brito-Mutunayagam R, Appleton SL, Wilson DH, Ruffin RE, Adams RJ. Global initiative for chronic obstructive lung disease stage 0 is associated with excess FEV(1) decline in a representative population sample. Chest 2010;138:605-13.
30. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-40.
31. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996;153:1530-5.
32. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005;6:98.
33. Ekberg-Aronsson M, Lofdahl K, Nilsson JA, Lofdahl CG, Nilsson PM. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary diseaseea population-based study. Respir Med 2008;102:109-20.
34. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105:907-15.